Search

Author/Creator Pyman, J

1. Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer. (27th November 2017)

Authors:
de Boer, S M; Wortman, B G; Bosse, T; Powell, M E; Singh, N; Hollema, H; Wilson, G; Chowdhury, M N; Mileshkin, L; Pyman, J; Katsaros, D; Carinelli, S; Fyles, A; McLachlin, C M; Haie-Meder, C; Duvillard, P; Nout, R A; Verhoeven-Adema, K W; Putter, H; Creutzberg, C L
Journal:
Annals of oncology
Issue:
Volume 29:Number 2(2018)
Page Start:
424
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P3.216 Assessing hpv genotype prevalence in infection and disease in young australian women following the introduction of a national vaccination program. (8th July 2017)

Authors:
Garland, Suzanne; Cornall, AM; Brotherton, JML; Osborne, SL; Wrede, CD; Wark, JD; Saville, M; Pyman, J; Tan, J; Callegari, ET; Gertig, DM; Jayasinghe, Y; Malloy, M; Pitts, M; Tabrizi, SN
Journal:
Sexually transmitted infections
Issue:
Volume 93(2017)Supplement 2
Page Start:
A173
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial. Issue 9 (September 2019)

Authors:
de Boer, Stephanie M; Powell, Melanie E; Mileshkin, Linda; Katsaros, Dionyssios; Bessette, Paul; Haie-Meder, Christine; Ottevanger, Petronella B; Ledermann, Jonathan A; Khaw, Pearly; D'Amico, Romerai; Fyles, Anthony; Baron, Marie-Helene; Jürgenliemk-Schulz, Ina M; Kitchener, Henry C; Nijman, Hans...
Journal:
Lancet oncology
Issue:
Volume 20:Issue 9(2019)
Page Start:
1273
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗